BioEclosion
Barcelona, Catalonia, Spain
About BioEclosion
BioEclosion seeks to enhance user-friendly quantitative diagnostics to new molecular biomarkers for fast identification of emerging diseases that affect global health. The company started its activity with several patents, the most important being Celifast: a non-invasive approach for the detection of celiac disease. Addressing point of care attention of patients, the core technology has been successfully validated and the team is currently working on further development for commercialization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (May 2021)
- Website: bioeclosion.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Hospital
Social Profiles
Canonical: https://fsome.com/organization/bioeclosion-2566087 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.